Alpha Tau 1st-Ever Brain-Cancer Patient Treated Outside the U.S.

 Alpha Tau Medical (NASDAQ: DRTS) announced yesterday that the first glioblastoma patient ever treated with Alpha DaRT outside the United States has undergone the procedure at Hadassah University Medical Center. The case is the latest in an unusually dense run of milestones for the small-cap oncology developer, arriving roughly three weeks after a major U.S. commercial partnership was signed and less than two weeks after the U.S. FDA cleared the Company’s pivotal brain-cancer trial to full enrollment.

https://finviz.com/news/363778/alpha-tau-medical-continues-its-winning-streak-with-first-ever-brain-cancer-patient-treated-outside-the-us